Imagine a world where you could harness the power of a trendy hormone treatment without the need for medication. That's exactly what Pura Collagen is aiming for with its groundbreaking entry into the GLP-1 market. But here's where it gets controversial: can a collagen-based supplement truly rival pharmaceutical options? Let's dive in.
This January 2026, Pura Collagen unveiled GLPure+, a powder supplement designed to naturally stimulate the body’s GLP-1 hormone response. Each serving packs 5,000mg of Nextida GC, a patented collagen peptide from Rousselot. Clinically proven to reduce post-meal glucose spikes by up to 43%, this ingredient is a game-changer for those seeking non-pharmaceutical alternatives. And this is the part most people miss: it’s not just about glucose control. GLPure+ also includes chromium for macronutrient metabolism and blood sugar regulation, vitamin C for collagen synthesis and fatigue reduction, and zinc for overall metabolic function. Together, these components create a holistic approach to metabolic health.
Jennifer Mo, Pura Collagen’s founder, shared that the inspiration behind GLPure+ stemmed from customer inquiries and emerging research. “Last year, GLP-1 medications were everywhere,” she noted. “It made me wonder if there was a clinically backed, non-pharmaceutical solution.” Customers were particularly concerned about side effects like skin changes (think ‘Ozempic face’) and muscle loss. While Mo emphasizes consulting a GP before combining supplements with medication, she saw an opportunity to address these worries head-on.
What’s truly fascinating is the science behind Nextida GC. Preclinical and human studies reveal it activates intestinal L- and K-cells, boosting incretin hormones like GLP-1 and GIP, which are crucial for glucose regulation and appetite control. But here’s a thought-provoking question: Could this natural approach eventually challenge the dominance of prescription GLP-1 drugs? Let’s discuss in the comments.
Pura Collagen didn’t stop there. Tapping into the booming digestive health market—projected to hit $106.47 billion by 2032—they launched Pura Digest. This product targets bloating, irregularity, and digestive discomfort with a blend of hydrolyzed collagen peptides, Biotis GOS, calcium, and vitamin C. The collagen peptides strengthen the gut lining, combating leaky gut syndrome, while Biotis GOS supports a balanced microbiome. In-house research revealed that 44% of consumers struggle with gut issues, and 59% are interested in prebiotic and probiotic solutions, making Pura Digest a timely addition.
Since its 2021 launch with ‘Glow+’ and ‘Flex+’, Pura Collagen has expanded to seven targeted powders, each addressing specific health needs. From ‘Sleep’ with magnesium and zinc to ‘Balance’ for hormonal support, the brand stays true to its mission: keeping ingredients as close to their natural form as possible. Even their packaging reflects this philosophy, with GLPure+ offered in portable sachets for convenience without compromising purity.
Mo credits the brand’s acquisition by Vector Consumer Ltd in 2024 for enabling this rapid innovation. “It gave us the breathing space to negotiate better terms and grow our team,” she explained. With a focus on bioactive collagen peptides and ongoing research, Mo is confident collagen’s potential is just being tapped. But here’s a bold prediction: as research expands, could collagen peptides become the next big thing in personalized health solutions?
What do you think? Is Pura Collagen onto something revolutionary, or is it too early to tell? Share your thoughts below!
